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Abstract
Background: A decline in the discovery of new antibacterial drugs, coupled with a persistent rise in the
occurrence of drug-resistant bacteria, has highlighted antibiotics as a diminishing resource. The future
development of new drugs with novel antibacterial activities requires a detailed understanding of adaptive
responses to existing compounds. This study uses Streptomyces coelicolor A3(2) as a model system to determine
the genome-wide transcriptional response following exposure to three antibiotics (vancomycin, moenomycin A
and bacitracin) that target distinct stages of cell wall biosynthesis.
Results: A generalised response to all three antibiotics was identified which involves activation of transcription of
the cell envelope stress sigma factor sE, together with elements of the stringent response, and of the heat,
osmotic and oxidative stress regulons. Attenuation of this system by deletion of genes encoding the osmotic stress
sigma factor sB or the ppGpp synthetase RelA reduced resistance to both vancomycin and bacitracin. Many
antibiotic-specific transcriptional changes were identified, representing cellular processes potentially important for
tolerance to each antibiotic. Sensitivity studies using mutants constructed on the basis of the transcriptome
profiling confirmed a role for several such genes in antibiotic resistance, validating the usefulness of the approach.
Conclusions: Antibiotic inhibition of bacterial cell wall biosynthesis induces both common and compound-specific
transcriptional responses. Both can be exploited to increase antibiotic susceptibility. Regulatory networks known to
govern responses to environmental and nutritional stresses are also at the core of the common antibiotic
response, and likely help cells survive until any specific resistance mechanisms are fully functional.
Background
The bacterial cell wall is a key target for antibiotic dis-
covery; it is crucial for cell growth, and provides a physi-
cal protective barrier between the cell and its
environment. Antibiotics that inhibit bacterial cell wall
biosynthesis, such as penicillin and vancomycin, are
extremely important in the clinical treatment of infec-
tious diseases. Free living bacteria resident in soil and
marine environments produce a vast array of chemically
diverse biologically active molecules, and the actinomy-
cete Streptomyces spp. in particular are a rich source of
antibiotics [1,2]. Antibiotics do not kill the organisms
that produce them since they have co-evolved systems
that make them resistant or tolerant to their effects, but
it is when similar systems develop in the target patho-
genic bacteria allowing them to survive antibiotic
treatments that major problems arise. The increase in
the number of cases of methicillin-resistant Staphylococ-
cus aureus (MRSA), and the emergence of vancomycin-
resistant MRSA in hospital-acquired infections are two
such examples [3-6].
Understanding how antibiotics can fail to be effective
against bacteria has the potential both to provide novel
insights into their mode of action, and to suggest new
targets for anti-infective therapy. In this study we use
Streptomyces coelicolor A3(2) as a model system to rig-
orously analyse the dynamic transcriptional response to
sub-lethal concentrations of three antibiotics (vancomy-
cin, bacitracin and moenomycin A) that target distinct
stages of cell wall biosynthesis. Streptomyces species pro-
duce about 70% of known antibiotics and are likely to
be the ultimate source of most clinically relevant anti-
biotic resistance genes. Consequently they possess many
genes involved in sensing and responding to extracellu-
lar antibiotics, and provide an excellent opportunity to
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understand the processes involved. S. coelicolor exhibits
significant resistance to vancomycin (minimum inhibi-
tory concentration (MIC) ~80 μg/ml), bacitracin (MIC
~45 μg/ml) and moenomycin ((MIC ~300 μg/ml), and
learning how the presence of these compounds, and the
damage to the cell wall that they cause, is communi-
cated to the bacterial chromosome, and how the subse-
quent reprogramming of gene expression acts to
counteract this damage, can provide new ideas for drug
discovery or for prolonging the therapeutic usefulness of
existing compounds. Indeed, a biochemical analysis of
the VanRS two-component sensor system of S. coelicolor
recently defined exactly how bacteria sense vancomycin,
a mechanism that triggers resistance to the only antibio-
tic in widespread use for the treatment of MRSA [7].
The development of techniques for studying gene
transcription on a genome-wide scale allows characteri-
sation of the response to antibiotic exposure, and several
recent studies have used DNA microarrays to analyse
the effect of antimicrobial compounds on bacterial
strains [8-13]. However, only a minority have focused
on antibiotics active against the cell wall, and these have
tended to use either lethal drug concentrations, or to
analyse only one time point following treatment. In this
work we have studied three time points after treatment,
and use the antibiotics at concentrations well below
their MIC. Sub-lethal concentrations of antibiotics have
been reported to be optimal for data quality in this type
of study [14], perhaps because bacteriocidal levels seem
ultimately to result in the same mechanism of cellular
death, thereby obscuring the link between the transcrip-
tional response to the antibiotic and its mode of action
[8].
Vancomycin, a glycopeptide antibiotic, inhibits the
transpeptidase reaction that occurs as one of the final
steps in peptidoglycan biosynthesis not by binding to
the enzyme but to the enzyme substrate, the D-alanyl-
D-alanine terminus of the pentapeptide of the peptido-
glycan precursor lipid II [15]. Moenomycin A is a mem-
ber of the phosphoglycolipid family of antibiotics, the
only natural products known to target directly the trans-
glycosylase enzyme that catalyzes polymerization of the
peptidoglycan sugar backbone prior to transpeptidase-
mediated cross-linking [16]. Bacitracin is a branched
cyclic dodecylpeptide antibiotic that inhibits cycling of
lipid II by binding to the lipid II carrier undecaprenol
pyrophosphate [17,18]. By characterising the transcrip-
tional response over a period of 90 min following treat-
ment with each of these antibiotics we identified
expression changes common to two or more com-
pounds, or unique to each antibiotic. These genes are
likely to be involved in adaptation or resistance to the
antibiotics, the former representing a generalised
response to cell wall damage, and the latter the
antibiotic-specific responses. Antibiotic susceptibility
studies using mutant strains selected for analysis on the
basis of the microarray results confirmed a role for sev-
eral genes in contributing to antibiotic resistance, vali-
dating the utility of this approach.
Results
Exposure of S. coelicolor to antibiotics that inhibit
different stages of peptidoglycan biosynthesis induced
changes in transcription in up to 27% of the genome
Transcriptome analysis identified 2094 genes whose
expression was significantly different at the 1% probabil-
ity level, and more than 1.5-fold up- or down-regulated,
as a result of exposure of exponentially growing S. coeli-
color cells to vancomycin, bacitracin or moenomycin A
(Figure 1, Additional files 1, 2, 3 and 4). This corre-
sponds to 27% of the 7,825 genes predicted to make up
the genome [1], and includes 1162 genes that were
repressed at one or more time points after antibiotic
addition, and 1062 genes whose expression was up-regu-
lated. 130 genes were common to both the repressed
and induced lists. For each antibiotic treatment, the
majority of the genes identified as induced or repressed
were present in at least two of the three time points
analysed (Figure 1A and 1C). Strikingly, only a minority
(0.06%) of the 1147 genes (68/1147) changing in expres-
sion in response to bacitracin treatment responded
uniquely to this compound; the vast majority were simi-
larly affected by vancomycin or by all three drugs (see
Figure 1B). In contrast, 42% (454/1079) of the genes sig-
nificantly down-regulated following addition of vanco-
mycin responded only to this compound, and 31% (235/
744) were also uniquely induced. Moenomycin treat-
ment notably down-regulated the expression of far
fewer genes than either vancomycin or bacitracin, and
16% of these (30/184) responded uniquely. Moenomycin
however up-regulated a similar number of genes to
either vancomycin or bacitracin, approximately 60%
(364/616) of which were also induced by one or more of
the other antibiotics, while 40% (252/616) were uniquely
induced. Interestingly, a core set of 243 genes were up-
regulated in response to any one of the compounds and
118 were similarly down-regulated, representing a com-
mon response to the antibiotic treatments.
To determine the similarities and differences in the
effects of each drug, the differentially expressed sets of
genes illustrated in Figure 1 were subjected to gene
ontology (GO) analysis (Additional files 5, 6, 7, 8, 9, 10
and 11), and compared with in-house curated sets of
functionally related genes (Tables 1 and 2, Additional
file 12). The latter approach was included since the
computationally generated GOA annotation available for
the S. coelicolor proteome (see Methods) has not been
manually curated and is therefore incomplete. The
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Figure 1 Changes in gene expression following antibiotic treatment affect 2094 (27%) of the 7825 genes in the S. coelicolor genome,
with many genes responding to more than one drug. A) Genes significantly repressed (left) or induced (right) following addition of
vancomycin (Van), bacitracin (Bac) or moenomycin A (Moe). Black bars represent genes that were significantly differently expressed at all three
time points after treatment, white bars correspond to genes affected at any two out of the three time points, and grey bars indicate those
changed at only one of the three time points. A fold-change cut-off value of 1.5 was used, and all genes are significantly differently expressed at
the 1% probability level. B) Venn diagrams showing the genes from Figure 1A that respond to more than one drug, or uniquely to individual
treatments. C) Heat maps showing the expression profiles of the differentially expressed genes identified in Figures 1A and 1B under all
conditions analysed. The columns represent the time in minutes following the antibiotic or control (Ctrl) treatments, and the rows correspond to
genes. The log2 expression values for each gene are represented by the colours according to the key scales shown, and the rows have been
clustered with NeatMap using the average linkage method [88].
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Table 1 Comparison of genes significantly induced following drug treatment with in-house curated lists of genes.
Entity list Genes in
entity list
present on
microarray
Vancomycin-induced
(744 genes)
Bacitracin-induced
(481 genes)
Moenomycin-induced
(616 genes)
Induced by all
(243 genes)
Genes in
entity list
matched with
induced genes
P-Value Genes in
entity list
matched with
induced genes
P-Value Genes in
entity list
matched with
induced genes
P-Value Genes in
entity list
matched with
induced genes
P-Value
SigB regulon 87 39 <1E-33 33 <1E-34 42 <1E-10 29 <1E-11
Heat shock regulon 119 51 <1E-33 27 3.13E-09 43 <1E-10 26 <1E-11
ppGpp-induced genes 98 50 1.46E-25 42 <1E-34 28 1.48E-09 20 <1E-11
Gas vesicle 1 8 8 7.71E-09 7 2.81E-08 7 1.58E-07 7 2.33E-10
SigE operon 4 4 8.87E-05 4 1.54E-05 4 4.16E-05 4 9.92E-07
Ectoine biosynthesis 4 4 8.87E-05 4 1.54E-05 4 4.16E-05 4 9.92E-07
CDA 47* 39 1.96E-32 35 6.87E-33 11 0.00100 11 1.67E-07
Peptidoglycan biosynthesis (external) 16 8 4.87E-05 5 0.00234 5 0.00686 4 0.001335
Sigma factors 64 14 0.00283 14 3.23E-05 11 0.01230 8 8.76E-04
Red 23* 23 3.83E-24 9 5.25E-06
Wbl 10 5 0.00142 3 0.02123
SsgA like 8 4 0.00450 3 0.01089
Cell wall hydrolyases 57 9 0.00856 14 1.23E-04
ppGpp-repressed genes 189 28 0.00111
Resuscitation-promoting factors 7 5 6.09E-05
Gly Ser Thr biosynthesis 35 9 0.00140
NRPS type II FAS 10 4 0.00589
Amino acid metabolism 184 24 0.01225
SigR regulon 26 6 0.01517
Hopanoids 13 4 0.01651
Amino acid transport 34 7 0.01675 4 0.0217
Methionine biosynthesis 9 3 0.03018
Lysine bioysnhtesis 16 4 0.03468
Val Leu Ile biosynthesis 25 5 0.04587
Sensor kinase 48 10 6.56E-04
Response regulators 94 11 0.0329
Zur regulon 22 19 5.50E-17
van cluster genes 7 7 8.00E-08
Coelibactin 13 7 8.11E-05
*indicates the number of probe sets rather than the number of genes.
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Table 2 Comparison of genes significantly repressed following drug treatment with in-house curated lists of genes.
Entity list Genes in
entity list
present on
microarray
Vancomycin-repressed
(1079 genes)
Bacitracin-repressed
(666 genes)
Moenomycin-repressed
(184 genes)
Repressed by all
(118 genes)
Genes in
entity list
matched with
repressed genes
P-Value Genes in
entity list
matched with
repressed genes
P-Value Genes in
entity list
matched with
repressed genes
P-Value Genes in
entity list
matched with
repressed genes
P-Value
Amino acid metabolism 184 69 <1E-30 49 1.21E-11 9 0.033121
ppGpp-repressed genes 189 147 <1E-30 114 <1E-16 35 <1E-09 25 <1E-10
Ribosomal protein genes 53 44 2.09E-29 27 1.57E-15 4 0.03798 3 0.0479
tRNA synthetases 28 21 5.03E-13 18 3.77E-13 3 0.028817 3 0.0088
Conservons 51 28 8.20E-12 24 1.02E-11 11 2.37E-08 10 3.87E-09
Coelichelin 12 12 5.85E-11 12 1.72E-13 2 0.032389 2 0.014
ABC transport 227 44 0.01568 48 3.85E-09 22 2.04E-08 10 0.0025
Glutamate biosynthesis 27 8 0.02838 7 0.00694 4 0.003681 3 0.0079
LAXTG sortase substrate 14 5 0.03678 5 0.00506 4 2.68E-04 4 4.77E-05
Conservon cvn13 4 4 3.93E-04 4 5.96E-05 3 5.37E-05 3 1.41E-05
Conservon cvn5 4 4 1.53E-07 4 5.96E-05 4 3.24E-07 4 5.37E-08
ATP synthesis 8 8 8.99E-07 7 2.72E-07
Vitamin B12 biosynthesis 11 9 1.74E-06 7 8.86E-06
Peptidoglycan biosynthesis (cytoplasmic) 14 10 6.31E-06 9 3.65E-07
Gly Ser Thr biosynthesis 35 16 3.93E-04 12 2.19E-05
Conservon cvn10 4 4 3.93E-04 4 5.69E-05
Conservon cvn12 4 4 3.93E-04 4 5.69E-05
Conservon cvn1 4 4 0.00168 2 0.04030
SigB regulon 87 23 0.00698 13 0.03697
SigR regulon 26 9 0.01000 8 0.00120
Conservon cvn4 4 3 0.00425 2 0.04030
Methionine biosynthesis 9 5 0.00412 3 0.03702
Phe Tyr Trp biosynthesis 33 11 0.00280 9 0.00155
Conservon cvn2 3 3 2.78E-04 2 0.02138
Val Leu Ile biosynthesis 25 11 7 0.00437
Conservon cvn6 4 2 0.04030 3 5.37E-05 2 0.0013
Amino acid transport 34 5 0.001202
Carotenoid 7 2 0.01
Desferrioxamines 4 3 0.00245 1151
Histidine biosynthesis 26 6 0.02161
Lysine biosynthesis 16 8 6.83E-04
H
esketh
et
al.BM
C
G
enom
ics
2011,12:226
http://w
w
w
.biom
edcentral.com
/1471-2164/12/226
Page
5
of
19
results of these analyses are summarised in the following
sections.
Common changes in expression of known stress-response
genes following antibiotic treatment suggest a general
environmental stress response system in S. coelicolor
i) The sE cell envelope stress response system is induced by
all three drugs
sE is an extracytoplasmic function sigma factor required
for normal cell envelope integrity in S. coelicolor, and its
expression is induced by a wide-variety of cell wall
damaging agents [19]. Reassuringly, transcription of the
four-gene operon containing the sE gene was signifi-
cantly induced following treatment with each of the
antibiotics (Table 1, Figure 2). In addition, similarity
analysis indicated that the expression of 158 genes was
closely correlated with that of sE (Pearson correlation
>0.9; Additional file 13). This group is likely to include
genes directly dependent on sE for their transcription,
and indeed contains shrdD (SCO3202) previously charac-
terised to be dependent on sE for expression [20]. Inter-
estingly, expression of the only aminoacyl-tRNA
synthetase gene (SC03397) to be up-regulated in
response to any drug correlates with sE transcription
(similarity coefficient = 0.93); of the remaining 27 tRNA
synthetase genes annotated in the genome sequence,
transcription of 21 was significantly repressed following
antibiotic treatment. Mutation in SCO3397, encoding a
lysyl-tRNA synthetase, markedly reduced the MIC
towards both vancomycin and bacitracin (Table 3) indi-
cating that it plays an important role in resistance to
these compounds.
ii) Effects caused by exposure to cell wall antibiotics show
significant similarity to those resulting from synthesis of the
stringent factor ppGpp
The stringent factor ppGpp is an intracellular signalling
molecule that is synthesised in S. coelicolor in response
to amino acid limitation, and which co-ordinates an
adaptive response to the changing nutritional conditions
that includes down-regulation of processes associated
with active growth, and up-regulation of systems that
may help it survive the nutritional stress [21]. Compari-
son of the lists of genes that were down-regulated in
response to antibiotic treatment with the genes shown
to be repressed following controlled induction of ppGpp
synthesis [21] revealed a significant commonality for
each of the compounds (Table 2). The 118 genes down-
regulated in response to all three antibiotics were also
significantly enriched for ppGpp-repressed genes, con-
taining 25/189 (p-value < 1E-10; Additional file 12).
These included 9 genes from conservons 5, 6 and 13.
Conservons are conserved operons believed to encode
membrane-associated signalling complexes [22], and
more than half of the 51 cvn genes (from cvns 1, 2, 4, 5,
6, 10, 12 and 13) were repressed by bacitracin or vanco-
mycin, while 11 (from cvns 5, 6, and 13) were repressed
by moenomycin. In addition, ppGpp-induced genes
were significantly over-represented in each of the vanco-
mycin-, bacitracin-, and moenomycin-induced lists
(Table 1), and in the 243 genes commonly induced by
all of the antibiotics (Additional file 12).
To investigate the possibility that an increase in
ppGpp synthesis helps mediate the observed responses
to the antibiotic treatments, intracellular nucleotide
pools were measured in cultures following exposure to
vancomycin. No increase in ppGpp synthesis was
observed at 15, 30 or 60 min following addition of van-
comycin, but ATP and GTP pools were reduced on
average by 23% and 35% after 15 min, respectively (data
not shown). MIC tests indicated that a relA mutant
strain that is incapable of ppGpp synthesis [23] is more
susceptible to both bacitracin and vancomycin (Table 3).
iii) Antibiotic treatment induces changes in expression of
many genes from the heat, osmotic and oxidative stress
regulons
Recent studies by Bucca et al. [24] and Lee et al. [25]
characterised the heat-shock regulon and sB-dependent
salt-stress regulon in S. ceolicolor, identifying 119 and
87 genes, respectively. Comparison of the genes signifi-
cantly differently expressed in response to antibiotic
treatment in this study indicated a significant overlap
between the sets of data (Tables 1 and 2). The 744
genes up-regulated in response to vancomycin contained
51 of the 119 genes reported by [24] to be up-regulated
in response to heat shock, an over-representation with a
significance p-value of <1 E-33. Almost half of the sB-
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Figure 2 The sE signal transduction system is induced
following treatment with vancomycin, bacitracin or
moenomycin. The fold-change increase in expression at 30, 60 and
90 min following addition of vancomycin (Van), bacitracin (Bac) or
moenomycin A (Moe) is shown, relative to the level of expression in
the corresponding sample of the untreated control culture (Ctrl).
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dependent salt-stress regulon genes (39/87) were simi-
larly present (p-value <1 E-33), while the 616 and 481
genes induced by moenomycin and bacitracin, respec-
tively, contained 42/87 and 33/87 of the salt stress
genes, and 43/119 and 27/119 of the heat shock genes,
respectively. Indeed, of the 243 genes commonly up-
regulated in response to all three antibiotics, 26
belonged to the heat shock regulon and 29 to the sB-
dependent salt-stress regulon. A sB-deletion mutant
showed a lowered MIC for both bacitracin and vanco-
mycin when compared to the parent strain (Table 3),
indicating an important role for sB in responding to cell
envelope stress.
Genes from the well-characterised sR regulon respon-
sible for disulphide bond homeostasis in response to
oxidative stress [26] were significantly over-represented
in both the vancomycin- and bacitracin-repressed gene
lists, suggesting a decrease in sR-mediated transcrip-
tional activity after antibiotic treatment.
iv) Vancomycin, bacitracin and moenomycin up-regulate
ectoine biosynthesis and genes for gas vesicle production
Ectoine is a pyrimidine carboxylic acid derivative that
serves as a compatible solute in several bacterial species,
protecting against salt and also temperature stress
[27-32]. Exogenous addition of ectoine and 5-hydroxyec-
toine to S. coelicolor cultures confers protection against
salt and heat stress, and a cluster of genes (SCO1864-
1867) homologous to the ectABCD gene cluster required
for ectoine biosynthesis in other bacteria was identified
in the S. coelicolor genome sequence [33]. GO terms for
ectoine biosynthesis and production were significantly
over-represented in the lists of genes induced following
exposure to each of the three antibiotics and the
ectABCD homologues were up-regulated at all three
time points after their addition (see Additional files 1,2
and 3, Additional file 14 Figure 1g). Genes required for
gas vesicle biosynthesis were similarly induced, but only
those from one of the two gvp gene loci, gvp1 (Table 1,
Additional files 1, 2 and 3, Additional file 14 Figure 1h).
A strong induction of gvp1 gene expression has also
been reported following exposure to high concentrations
of salt, and it has been proposed that gas vesicles play a
role in the response to hyperosmotic stress [34].
In MIC tests, supplementation of the agar media with
1 mM ectoine provided no significant protection against
the effects of either bacitracin or vancomycin (data not
shown).
Changes in expression of genes with functions related to
production and maintenance of the cell wall show
antibiotic-specificity
i) Genes required for cell wall peptidoglycan biosynthesis
Bacterial cell wall peptidoglycan biosynthesis can be
separated into reactions occurring intracellularly to
Table 3 Minimum inhibitory concentration (MIC) test of mutant strains carrying disruptions in genes targeted based
on their transcriptome profiles.
Strains Relevant genotype/comments MIC (μg/ml) Source/reference
Vancomycin Bacitracin Moenomycin
S. coelicolor A3(2) (M600) SCP1- SCP2- ~80 40-45 >300 Kieser et al. 2000 [81]
ΔSCO0600 (H1001) ΔsigB::apr SCP1- SCP2- 60-70 25-30 >300 This study
ΔSCO3356 (J2130) ΔsigE SCP1- SCP2- 60-70 35-40 >300 Paget et al. 1999 [20]
ΔSCO1513 (M570) ΔrelA SCP1- SCP2- 60-70 20-25 >300 Chakraburtty and Bibb.
1997 [23]
ΔSCO3089-3090 (H1003) ΔSCO3089-3090::apr SCP1- SCP2- 70-80 15-20 >300 This study
ΔSCO3110-3111 (H1002) ΔSCO3110-3111::apr SCP1- SCP2- 70-80 30-35 >300 This study
ΔSCO3089-3090 + ΔSCO3110-3111
(H1004)
ΔSCO3089-3090 + 3110-3111::apr
SCP1- SCP2-
70-80 <10 >300 This study
SCO4005::Tn (M900) SCO4005::Tn SCP1- SCP2- 70-80 25-30 >300 Hesketh et al. 2007 [21]
SCO5147::Tn (M903) SCO5147::Tn SCP1- SCP2- 80-90 40-45 >300 Hesketh et al. 2007 [21]
ΔSCO1875 (H1005) ΔSCO1875::apr SCP1- SCP2- <50 10-15 >300 This study
ΔSCO2608 (H1006) ΔSCO2608::apr SCP1- SCP2- 60-70 40-45 >300 This study
SCO2897::Tn (H1007) ΔSCO2897::Tn SCP1- SCP2- ~60 30-35 >300 This study
SCO3580::Tn (H1008) ΔSCO3580::Tn SCP1- SCP2- <50 40-45 >300 This study
SCO3771::Tn (H1009) ΔSCO3771::Tn SCP1- SCP2- <50 40-45 >300 This study
ΔSCO3847 (H1010) ΔSCO3847::apr SCP1- SCP2- ~60 40-45 >300 This study
SCO3901::Tn (H1011) ΔSCO3901::Tn SCP1- SCP2- ~60 40-45 >300 This study
ΔSCO4013 (H1012) ΔSCO4013::apr SCP1- SCP2- 70-80 40-45 >300 This study
SCO5039::Tn (H1013) ΔSCO5039::Tn SCP1- SCP2- 60-70 40-45 >300 This study
ΔSCO3397 (J3355) ΔSCO3397::apr SCP1- SCP2- <50 10-15 >300 This study
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generate the lipid II precursor subunits, and those tak-
ing place extracellularly to join the subunits together
into a three dimensional structure [35-42] (Figure 3A).
Transcription of many of the genes for the cytoplasmic
steps required for precursor biosynthesis, particularly
the mur operon (SCO2083-2089) and the femX gene
(SCO3904), were significantly repressed following treat-
ment with either bacitracin or vancomycin, but were
unchanged following moenomycin addition (Table 2,
Figure 3B). In contrast, genes encoding penicillin-bind-
ing proteins (PBPs) required for the extracellular reac-
tions in peptidoglycan production were over-represented
in the genes induced by all three antibiotics (Table 1,
Figure 3B). The secreted PBPs SCO1875, SCO2897 and
SCO5039 were significantly induced following treatment
with each compound, while SCO2608 was induced by
vancomycin and moenomycin but not by bacitracin. In
MIC tests, deletion of SCO1875 markedly increased sus-
ceptibility to both bacitracin and vancomycin (Table 3)
indicating that this PBP is essential for optimum resis-
tance to these compounds, and suggesting that up-regu-
lation of its transcription is an important response to
the antibiotic treatments. Deletion of SCO2897 also
increased susceptibility to both antibiotics (lowered the
MIC), while mutation in SCO2608 and SCO5039
increased sensitivity to vancomycin only (Table 3). Van-
comycin treatment alone down-regulated expression of
SCO2090, SCO3901 and SCO4013, and was the only
antibiotic to up-regulate transcription of SCO3156 and
SCO3847. Consistent with this, deletion of SCO3847
slightly lowered the MIC for vancomycin but showed no
effect with bacitracin (Table 3). The PBP encoded by
SCO3157 was up-regulated by both vancomycin and
bacitracin but not by moenomycin.
The previously characterised van gene cluster respon-
sible for remodelling peptidoglcan precursor biosynth-
esis to produce subunits terminating in D-alanyl-D-
lactate (rather than D-alanyl-D-alanine) was, as
expected, induced strongly only by vancomycin, and not
by either of the other two antibiotics [43,44](Figure 3B).
vanH, encoding D-lactate dehydrogenase, exhibited the
largest change in expression observed for any gene: a
300-fold increase 90 min after vancomycin addition.
ii) Genes encoding cell wall remodelling enzymes and
sortase substrates
In addition to peptidoglycan biosynthesis, hydrolysis of
the cell wall is an important process for growth allowing
remodelling of cell shape to enable expansion and differ-
entiation. Haiser et al. [45] identified 57 putative cell
wall hydrolase genes in the S. coelicolor genome in an in
silico search, and confirmed that four could efficiently
degrade S. coelicolor cell walls using biochemical
approaches. In this study, genes encoding cell wall
hydrolases were significantly over-represented in the
lists of genes up-regulated in response to bacitracin or
moenomycin, but not vancomycin (see Table 1). In
total, expression of 23 of the 57 genes were significantly
affected following treatment with one or more of the
cell wall antibiotics, only a minority (four) of these how-
ever responded in a similar way to all three compounds
(Additional file 14 Figure 1e). Seven genes were up-
regulated only in response to moenomycin, and four of
these were actually repressed following treatment with
at least one of the other two antibiotics. In total 13 of
the 23 genes were down-regulated in response to either
bacitracin or vancomycin, while moenomycin treatment
did not negatively affect transcription of any. Interest-
ingly, of the seven members of the resuscitation-pro-
moting factor (Rpf) subgroup of hydrolases, five were
significantly induced in response to moenomycin. Only
rpfA (SCO3097) was induced by all three antibiotics,
with expression of the SCO3098 homologue induced by
bacitracin and moenomycin, but significantly repressed
following vancomycin treatment (Additional file 14 Fig-
ure 1e). rpfA and SCO3098 encode proteins with puta-
tive LysM peptidoglycan-binding domains, and RpfA has
been shown to hydrolyse S. coelicolor peptidoglycan
[45]. Of the three other rpf homologues induced by
meonomycin, SCO5029 was repressed following bacitra-
cin and vancomycin treatment, while SCO0974 expres-
sion was down-regulated by bacitracin. Transcription of
SCO3150 was not significantly affected by either vanco-
mycin or bacitracin. The Nlp60-family cell wall hydro-
lase encoded by SCO4108 was induced in response to
both bacitracin and moenomycin, but repressed by van-
comycin. Vancomycin and bacitracin strongly induced
both SCO5487 (amidase family) and SCO5660 (carboxy-
peptidase family), while moenomycin up-regulated only
the former of these two genes.
Septum synthesis and localisation is a specialised
aspect of cell wall biosynthesis important for cell divi-
sion and sporulation in S. coelicolor. SsgA-like proteins
are intimately involved in developmental cell division in
streptomycetes, and although their precise function has
yet to be fully characterised they are believed to control
the fate of peptidoglycan during sporulation [46,47].
SsgA-like proteins were significantly over-represented in
the vancomycin- and bacitracin-induced gene lists (see
Table 1), and ssgR (SCO3925), the regulator activating
transcription of ssgA (SCO3926), was induced 2-to 6-
fold at all times following treatment with vancomycin
(Additional file 14 Figure 1o). Expression of ssgD
(SCO6722) was significantly up-regulated by all three
antibiotics, while ssgE (SCO3158) was induced by vanco-
mycin and moenomycin only.
Sortase enzymes are transpeptidases that covalently
link proteins to peptidoglycan in many Gram-positive
bacteria [48]. Substrate proteins are recognisable from
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Figure 3 Bacterial cell wall peptidoglycan biosynthesis and the effects of bacitracin (Bac), moenomycin (Moe) and vancomycin (Van).
(A) The intracellular and extracytoplasmic steps of peptidoglycan biosynthesis in S. coelicolor illustrating the different reactions inhibited by each
antibiotic. (B) Heatmap summarising the significant changes in expression of genes involved in bacterial cell wall peptidoglycan biosynthesis
following treatment with Bac, Moe or Van. Genes are grouped according to their involvement in the cytoplasmic (i) or extracytoplasmic (ii)
stages of biosynthesis illustrated in Figure 3A, or known involvement in the synthesis of alternate cell wall precursors (the van gene cluster,
Hong et al. [43]) (iii). Genes significantly up- or down-regulated relative to the control (Ctrl) are indicated by a + or -, respectively, and the
magnitude of the change is colour coded according to the legend shown. Genes not significantly differently expressed by one of the antibiotics
relative to the control are represented by faded boxes.
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the presence of amino acid sequence motifs, most nota-
bly by a conserved C-terminal LP(A)XTG sequence.
Genes encoding 17 substrate proteins were identified in
S. coelicolor [49], and presumably play a role in cell wall
structure and function. For example, three are known to
encode chaplin proteins that assemble as a hydrophobic
coat during aerial mycelium formation when cultured
on solid agar media [50]. Genes encoding sortase sub-
strates were significantly over-represented in the lists of
genes repressed by each of the drugs (see Table 2), with
six genes significantly altered in expression following
treatment with one or more of the antibiotics (Addi-
tional file 14 Figure 1n). Four (SCO2492, SCO2682,
SCO3176 and SCO5650) were down-regulated in com-
parison to the control experiment by all three com-
pounds, while SCO2270 was repressed only by
bacitracin and vancomycin. SCO1023, encoding a pro-
tein of unknown function, was induced in response to
all three antibiotics. As expected, expression of the cha-
plin genes was not significantly altered since cells were
grown in submerged liquid culture where aerial myce-
lium formation does not take place.
The biosynthesis of antibiotics is induced in response to
cell wall specific drugs
In the gene ontology analysis (Additional files 5, 6,7, 8,
9, 10 and 11), the GO term for acyl carrier activity was
prominent in the lists from the term-for-term and
MGSA analysis of genes induced by vancomycin or
bacitracin in the 90 min sample, with as many as 8
genes associated with this term present in the lists of
up-regulated genes. These correspond to four genes
each from the biosynthetic clusters responsible for pro-
ducing the antibiotics CDA and undecylprodiginine
(Red), and indicate that activation of antibiotic produc-
tion is part of the cellular response to exposure to both
vancomycin and bacitracin. Indeed, 39 of the 47 CDA
cluster probe sets (corresponding to 32 of the 40 genes)
were up-regulated after addition of vancomycin, along
with all 23 Red cluster probe sets (22 of the 22 genes;
Table 1, Additional files 14 Figures 1d and 1i). The cor-
responding figures for bacitracin treatment were 35 and
9 probe sets, respectively, while moenomycin induced
11 probe sets from the CDA cluster. Activation of CDA
synthesis is therefore a common response to treatment
with all of the antibiotics. The expression of the CDA
and Red biosynthesis genes, and that of the only other
antibiotic biosynthetic gene cluster identified in the gen-
ome, the actinorhodin (Act) cluster, is ultimately depen-
dent on activation by regulatory proteins encoded by
each cluster [51-53]. The changes in expression of these
activator genes brought about by treatment with the cell
wall antibiotics is summarised in Table 4, and indicates
that vancomycin and bacitracin in particular had a
strong inducing effect on transcription of all four activa-
tors. Although an increase in expression of the actinor-
hodin biosynthesis genes was not observed in the 90
min in liquid culture following addition of any of the
antibiotics, vancomycin treatment induced production
of the blue pigmented antibiotic in a paper disc assay
using growth on a solid agar medium (Figure 4). This
response was markedly reduced, but not abolished, in
an M570 mutant defective in ppGpp synthesis, indicat-
ing that the signalling molecule is not essential for this
response to vancomycin.
Sigma factor gene expression is a major response to
exposure to cell wall antibiotics
S. coelicolor RNA polymerase can interact with any one
of 64 different sigma factors, each specifying recognition
of a different cognate consensus promoter sequence
[54]. Changes in the relative abundance of sigma factors
within a cell can therefore significantly influence the
pattern of gene transcription. Sigma factor genes were
significantly over-represented in the lists of genes
induced by each antibiotic (Table 1) indicating that
alteration in sigma factor gene expression is an impor-
tant response to treatment with antibiotics targeting cell
wall biosynthesis. This is also reinforced by the promi-
nence of genes known to be regulated by sE, sB and sR
in the differentially expressed gene lists (see Tables 1
and 2), and by the observed increase in susceptibility of
sE and sB mutant strains towards bacitracin and vanco-
mycin (see Table 3). Eight sigma factor genes, including
sE (SCO3356) and sB (SCO0600), were up-regulated
following treatment with all three compounds. Of these,
Table 4 Expression of the genes encoding the transcriptional activators for switching on production of the CDA, Red
and Act biosynthetic clusters is induced following exposure to vancomycin, bacitracin and moenomycin.
Antibiotic cluster Activator gene vancomycin Fold-change increase in expression in the 90 min sample1
Vancomycin Bacitracin Moenomycin
CDA cdaR (SCO3217) 5.4 2.4 1.5
Act actII-ORF4 (SCO5085) 2.8 1.6 1.5
Red redD (SCO5877) 11.4 4.4 2.1
Red redZ (SCO5881) 5.7 3.6 NA
1NA = the gene was not present in the list of significantly differently expressed genes in Additional files 1, 2 and 3.
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the genes encoding the putative extra-cytoplasmic func-
tion (ECF) sigma factors encoded by SCO4005,
SCO4908 and SCO5147 were particularly strongly
induced (5- to 7-fold by vancomycin; Additional file 14
Figure 1l). A mutant strain in which SCO4005 was dis-
rupted by insertion of a transposon showed increased
susceptibility to bacitracin, but was not significantly
altered in its resistance to vancomycin (Table 3). How-
ever, a similar mutant in which SCO5147 had been dis-
rupted showed no increase in susceptibility to either
compound and was slightly more resistant to vancomy-
cin than the parental strain (Table 3). Transcription of
the alternative sigma factor shrdD (SCO3202) known to
be dependent on sE [20] was also up-regulated by all
three antibiotics, while the expression of sbldN
(SCO3323), a sigma factor important for S. coelicolor
differentiation [55], was repressed by all three. Vanco-
mycin alone repressed transcription of four other sigma
factor genes (SCO3068, SCO3626, SCO5216 (sR), and
SCO5243); two of these, including sR, were up-regulated
after treatment with at least one of the other two anti-
biotics. Consistent with this, genes from the sR-regulon
were significantly over-represented in both the vanco-
mycin-repressed and moenomycin-induced gene lists
(see Tables 1 and 2).
The zinc-responsive zur regulon is induced exclusively by
vancomycin
Zinc plays an indispensable role in cellular biochemistry
as a catalytic or structural cofactor for a wide variety of
metalloproteins. It can however be toxic if accumulated
to excess, and its intracellular concentration is con-
trolled within safe limits by homeostatic regulatory
mechanisms. In bacteria this is largely achieved by tight
control of import and export mechanisms via the zinc-
responsive regulatory protein Zur [56,57], and the Zur
regulon in S. coelicolor has recently been characterised
[58-60]. Interestingly in this work the majority of the
genes in the regulon, including the znuABC operon
(SCO2505-2507) encoding the high-affinity Zn2+ import
system, were transiently up-regulated following addition
of vancomycin but not by either of the other two anti-
biotics (Table 1, Additional file 14 Figure 1p). Expres-
sion of znuA (SCO2505) was induced 12-fold 30 min
after vancomycin addition, decreasing to about 2-fold
up-regulated by 90 min (see Additional file 3).
Genes required for branched chain amino acid and biotin
biosynthesis are induced by moenomycin
GO terms associated with amino acid biosynthesis were
over-represented in the genes induced in response to
moenomycin treatment (see Additional files 5, 6, 7, 8, 9
and 10). Comparison of the significantly differently
expressed genes with the groups of functionally related
genes in Tables 1 and 2 supported this observation,
indicating that moenomycin induced genes associated
with branched chain amino acid (leucine, isoleucine and
valine), lysine and methionine biosynthesis. Indeed, the
ilvD (SCO3345), leuB (SCO5522) and leuC (SCO5553)
genes for the biosynthesis of the branched chain amino
acids leucine, valine and isoleucine were up to 7-fold
up-regulated by moenomycin treatment (Additional file
14 Figure 1c). In addition, genes associated with the
transport of amino acids were over-represented in both
the moenomycin up-regulated genes, and those down-
regulated by the antibiotic (Tables 1 and 2). Interest-
ingly, the down-regulated genes included four from the
putative branched-chain amino acid import operon
SCO2008-2012 (Additional file 14 Figure 1a).
GO analysis of the 252 genes specifically up-regulated
by moenomycin in Figure 1B indicated a significant
over-representation not only of amino acid biosynthesis
M600lawn(ppGpp+) M570lawn(ppGppͲ)
100 1000
Vancomycin(ʅg)
Blank(water)

Figure 4 Exposure to vancomycin induces biosynthesis of the pigmented antibiotics Act and Red in S. coelicolor. This response is
markedly reduced in strain M570 that is defective in production of the stringent factor ppGpp. Spore lawns of the indicated strains were spread
on SMMS agar plates [81], and paper discs impregnated with vancomycin (or water) were applied to the surface. Cultures were incubated for 3
days at 30°C.
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genes, but also of biotin biosynthesis. The bioB-D
operon (SCO1244-1246) was approximately 2-fold up-
regulated in the 90 min moenomycin-treated sample.
Biotin is a cofactor implicated in catabolism of fatty
acids and branched chain amino acids, and up-regula-
tion of its production may indicate an increased use of
branched chain amino acids as an energy source in the
moenomycin treated cells. Indeed, expression of accD1
(SCO2776) encoding the biotin-dependent acetyl-CoA
carboxylase enzyme, a key enzyme in branched chain
amino acid degradation, was 5-fold up-regulated 90 min
after moenomycin addition (see Additional file 3).
Genes encoding two-component signal transduction
systems are specifically induced by bacitracin
GO analysis of the 39 genes whose transcription was
induced only in response to bacitracin (see Figure 1B)
indicated genes associated with two-component system
signal transduction as the most over-represented process
(see Additional file 11), with ten of the genes encoding
response regulator or sensor kinase proteins. These
included two clusters of three genes encoding a
response regulator-kinase-kinase (SCO4596-4598), and a
regulator-regulator-kinase (SCO3638, SCO3640 and
SCO3641). This implies that they represent multi-com-
ponent signal transduction systems that are important
for coordinating a response to bacitracin (but not moe-
nomycin or vancomycin). Other two-component system
genes uniquely up-regulated in response to bacitracin
were the SCO5683-5684 regulator-kinase pair, and the
kinases encoded by SCO2359 and SCO7649. Mutant
strains deleted for SCO3638-3641, SCO4596-4598 or
SCO5683-5684 did not however show any significant
change in their resistance to bacitracin (data not
shown).
Identification of novel ABC transport systems important
for bacitracin resistance
SCO3089-3090 and SCO3010-3011 encode putative
ABC transport proteins that show a high degree of
homology: SCO3089 is 75% identical to SCO3111 at the
amino acid level, while SCO3090 shows 38% identity
over its full-length to SCO3110 (Figure 5A). Transcrip-
tion of all four genes was strikingly up-regulated 30-fold
or higher in response to each of the three compounds
(Figure 5B, Additional files 1, 2 and 3), suggesting an
important role for these transporters in the response to
the antibiotic treatments. To test this further, mutant
strains carrying deletions in one or both of the transport
systems were constructed and analysed for their suscept-
ibility to vancomycin and bacitracin (Table 3 and Figure
5C). While the single and double mutant strains showed
at most only a marginal increase in susceptibility to
vancomycin, the double mutant strain H1004 exhibited
markedly increased susceptibility to bacitracin, reducing
the MIC to below 10 μg/ml compared to 40-45 μg/ml
for the parental strain. Both single mutant strains also
showed an increased susceptibility to bacitracin, but
MIC values (15-20 μg/ml for H1003 (ΔSCO3089-3090)
and 30-35 μg/ml for H1002 (ΔSCO3110-3111)) were
not as low as for the double mutant.
Discussion
Stress response genes contribute towards antibiotic
resistance in S. coelicolor
Vancomycin, bacitracin and moenomycin target dis-
tinctly different stages of cell wall biosynthesis (see Fig-
ure 3A), yet exposure of S. coelicolor to each antibiotic
resulted in changes in expression of many of the same
genes (see Figure 1). Previous studies on the role of the
ECF (extracytoplasmic function) sigma factor sE in
maintaining cell wall homeostasis in S. coelicolor identi-
fied a key role in responding to antibiotics that damage
the cell wall [19]. This study reveals that the transcrip-
tional response to vancomycin, moenomycin and baci-
tracin extends far beyond the involvement of sE,
incorporating elements of the heat shock response, the
stringent response, and the response to osmotic and oxi-
dative stress. Whether this reflects different, condition-
specific regulatory cascades influencing the same genes,
or triggering of the same regulatory cascade by different
stimuli is unclear. The failure of vancomycin to increase
synthesis of the stringent factor ppGpp while modulat-
ing expression of many stringently controlled genes sug-
gests the former, but simultaneous induction of
transcription of sB and the sB regulon, and of sE and
the sE-dependent gene SCO3202, by all three antibiotics
would be indicative of the latter. A combination of the
two appears likely. These stress responses were not
necessary for antibiotic resistance, but were required for
maximal resistance. A sB-deletion mutant strain and a
mutant defective in ppGpp synthesis both exhibited
increased susceptibility towards bacitracin and vancomy-
cin. S. coelicolor carries an inducible system that specifi-
cally confers high-level (MIC ~80 μg/ml) resistance to
vancomycin, and functions by reprogramming cell wall
precursor biosynthesis [43,44]. Although the van genes
involved are among the most highly induced in response
to vancomycin treatment at all time points tested (see
Figure 3B, Additional file 1), it is unlikely that cells
become instantly fully resistant to the effects of the anti-
biotic and expression of the stress response genes may
facilitate survival during this transition period. A transi-
ent slowing in growth was observed following treatment
with both vancomycin and bacitracin, consistent with
the existence of such a “stress” phase (data not shown).
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S. coelicolor is susceptible to bacitracin (MIC 40-45
μg/ml) but highly resistant to moenomycin (MIC >300
μg/ml). All of the mutants tested were also resistant to
300 μg/ml moenomycin. It is perhaps therefore not sur-
prising that moenomycin repressed the transcription of
many fewer genes than either bacitracin or vancomycin
(see Figure 1A). Interestingly however, moenomycin
activated the transcription of a comparable number of
genes to both vancomycin and bacitracin, including
genes from the heat shock regulon, the stringent
response, and the osmotic and oxidative stress regulons.
Treatment with 10 μg/ml moenomycin, although only a
fraction of the MIC, clearly induced a physiological
response, perhaps reflecting induction of mechanisms
for cell wall homeostasis well below inhibitory concen-
trations of the antibiotic or even a signalling role for the
compound (see below).
Identification of new genes with roles in antibiotic
resistance
Genes whose transcription was activated in response to
two or more of the compounds may be components of
a general response to treatment with antibiotics inhibit-
ing cell wall biosynthesis. Inactivation of two putative
ABC transporters, SCO3089-3090 and SCO3110-3111,
both markedly up-regulated after treatment with all
three antibiotics, significantly increased susceptibility to
bacitracin. The integral membrane proteins encoded by
these two systems are similar to lysophospholipase L1
and transport system components associated with lipo-
protein release (http://streptomyces.org.uk), possibly
suggesting a role in remodelling the cell envelope. Inter-
estingly, orthologous and syntenous systems also occur
in the genomes of Streptomyces clavuligerus, Strepto-
myces avermitilis and Streptomyces griseus, suggesting
A
SCO3089Ͳ3090 SCO3110Ͳ3111
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19genes
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Figure 5 Identification of novel ABC transport systems important for bacitracin resistance. A) Homologous pairs of genes encoding
putative ABC transport integral membrane (black arrow) and ATP-binding (grey arrow) proteins located close to each other on the
chromosome. B) Transcription of both transport systems is strongly up-regulated following treatment with bacitracin (Bac), moenomycin A (Moe)
and vancomycin (Van). Heatmap summarising the significant changes in expression of the genes relative to the control (Ctrl). The magnitude of
the change in expression is colour coded according to the legend shown. C) Deletion of the transport systems individually or together increases
susceptibility to bacitracin.
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conserved evolution and a common biological function.
The ECF sigma factor encoded by SCO4005 also contri-
butes to bacitracin resistance; identifying the SCO4005
regulon could provide new insights into how bacterial
cells cope with the antibiotic.
Of the other genes inactivated and analysed for their
effect on antibiotic resistance, only disruption of the
PBP encoded by SCO1875 and of the putative lysyl-
tRNA synthetase encoded by SCO3397 markedly
increased susceptibility to both bacitracin and vancomy-
cin. Transcription of both SCO1875 and SCO3397 is
markedly up-regulated following treatment with each of
the antibiotics and is therefore an important part of the
antibiotic resistance response. Navratna et al. [61]
reported that deletion of the gene encoding PBP4 in
Staphylococcus aureus increased susceptibility to vanco-
mycin and was associated with a reduction in cross-
linked muropeptide. PBP5 in Enterococcus faecalis is
required for resistance to cephalosporins [62]. None of
these three PBPs are essential for growth in their
respective organisms, yet modulation of their activities
appears to be an important component of the response
to compounds that inhibit peptidoglycan biosynthesis.
The response to vancomycin treatment included the up-
regulation of transcription of eight genes encoding puta-
tive PBPs, including two only induced by this antibiotic.
These observations, together with three PBPs genes
uniquely repressed following vancomycin addition are
discussed later. Of the 28 genes predicted to encode
tRNA synthetases in the S. coelicolor genome, only
SCO3397 was up-regulated following drug treatment,
the majority (21) typically being down-regulated. In
addition to their central role in protein biosynthesis,
aminoacyl-tRNAs are involved in porphyrin biosynthesis,
N-terminal protein modification, peptidoglycan bio-
synthesis and aminoacyl-phosphotidylglycerol biosynth-
esis [63]. SCO3397 is required for maximal resistance to
bacitracin and vancomycin in S. coelicolor, and homolo-
gous MprF proteins in Staphylococcus aureus and Lis-
teria monocytogenes have also been implicated in
resistance to antimicrobial peptides [64,65]. Although it
is not known whether SCO3397 possesses phospholipid
lysylination activity similar to MprF, this protein class
may represent a useful target for counteracting resis-
tance to antibiotics active against the cell envelope.
Genes responding uniquely to individual drug treatments
offer new insights into activity and resistance
While there were many similarities in the changes in
gene expression following treatment with vancomycin,
moenomycin or bacitracin, genes responding uniquely
to only one of the antibiotics were also identified (see
Figure 1B). Given the different activities of the three
compounds, these results potentially provide new
insights into the mode of action of, and mechanisms of
resistance towards, the individual antibiotics.
i) Vancomycin
In total, transcription of 235 genes was uniquely acti-
vated by vancomycin, while 454 were uniquely repressed
(see Figure 1B). As expected, the genes uniquely up-
regulated included the set of seven van genes previously
characterised as encoding an inducible resistance system
specific to this drug [43,44]. Surprisingly, they also
included 19/22 genes from the Zur regulon required for
zinc homeostasis [58-60] that were transiently but
strongly up-regulated in the 30 min sample. The impli-
cation is that vancomycin addition caused a decrease in
intracellular zinc availability that was subsequently cor-
rected via the Zur-dependent zinc starvation response.
How vancomycin causes zinc limitation is not known,
but could result from changes in the cell envelope that
favour zinc sequestration or perhaps via chelation of
zinc by the antibiotic itself (vancomycin interacts with
Cu2+ ions in vitro [66,67]). Transcription of five genes
encoding PBPs and therefore with putative roles in
extracellular peptidoglycan biosynthesis were uniquely
significantly affected by vancomycin treatment
(SCO3156 and SCO3847 were up-regulated while
SCO2090, SCO3901 and SCO4013 were repressed). It is
interesting to speculate that at least some of these
changes may be associated with the reprogrammed pep-
tidoglycan biosynthesis producing precursors terminat-
ing in D-alanyl-D-lactate and perhaps requiring PBPs to
match the changes in substrates. SCO5034-5035 encod-
ing a putative ABC transporter was 3.5-fold or more up-
regulated at all time points in response to vancomycin,
but not moenomycin or bacitracin (see Additional file
14, Figure 1b). The products of these genes are homolo-
gous to the transporters encoded by SCO3089-3090 and
SCO3110-3111 (about 20% identity between the per-
mease proteins, and 40% between the ATP-binding sub-
units) that are strongly induced in response to all three
antibiotics. Functional redundancy associated with van-
comycin-dependent expression may explain why the
double mutant strain H1004 (ΔSCO3089-3090 +
ΔSCO3110-3111) was sensitive to bacitracin but not to
vancomycin. Interestingly, the putative regulatory gene
SCO5036 immediately upstream of SCO5034-5035 was
also induced by vancomycin, and was >15-fold up-regu-
lated at all times following antibiotic treatment. From
their chromosomal arrangement these genes appear to
form a single transcription unit directed from a promo-
ter upstream of SCO5036.
ii) Bacitracin
Genes exclusively induced by bacitracin are particularly
interesting because none correspond to previously
known bacitracin resistance genes in other organisms,
such as bacA, bcrA, and bcrC [68-72]. This suggests that
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S. coelicolor may possess a novel mechanism for bacitra-
cin resistance. Treatment with bacitracin activated the
transcription of many two-component regulatory sys-
tems, including several whose strong induction was
unique to this antibiotic. In fact, about 25% of the genes
uniquely up-regulated in response to bacitracin treat-
ment encoded response regulators or sensor histidine
kinases. However, mutant strains carrying deletions in
individual sensory systems showed no change in sus-
ceptibility to bacitracin, indicating, in contrast to vanco-
mycin, the existence of multiple, functionally redundant
sensory systems. The bcrA and bcrC homologues
induced by bacitracin in this work were also similarly
up-regulated by at least one of the other two antibiotics,
and are therefore likely to be involved in a generalised
antibiotic response. Transcription of the bacA homolo-
gue SCO7047 was not significantly affected by any of
the antibiotics.
iii) Moenomycin A
Moenomycin A exposure was the only treatment that
activated transcription of genes required for amino acid
biosynthesis; vancomycin and bacitracin tended to
repress their expression. Genes encoding enzymes with
roles in branched chain amino acid biosynthesis were
particularly strongly induced, while those required for
their import were simultaneously repressed. While this
may reflect inhibition by moenomycin of the uptake of
these amino acids, it could also indicate an increase in
catabolism of branched chain amino acids. The latter is
supported by a simultaneous and moenomycin-specific
up-regulation in the catabolic enzyme accD1 and in
genes required for the biosynthesis of biotin, an impor-
tant cofactor for catabolic processes. Branched chain
amino acids are important precursors in secondary
metabolite biosynthesis, and their availability can affect
secondary metabolite production in S. coelicolor [73].
Preferential use of these precursors for energy yielding
catabolic processes in the moenomycin-treated cells
could potentially explain the lack of activation by moe-
nomycin of the secondary metabolic pathways for CDA
and Red.
Induction of antibiotic biosynthesis following antibiotic
treatment: chemical warfare in the soil?
S. coelicolor M600 produces three antibiotics, actinorho-
din (Act), undecylprodiginine (Red) and the calcium-
dependent antibiotic CDA. Strikingly, expression of the
regulatory genes required for activating transcription of
all three biosynthetic gene clusters was up-regulated
within 30-60 min of exposure to both vancomycin and
bacitracin, and was accompanied by a marked increase
in transcription of the Red and CDA biosynthesis genes.
Moenomycin also induced the CDA biosynthetic gene
cluster. Production of the pigmented antibiotics Act and
Red in response to vancomycin treatment was readily
detectable in an agar disc assay (see Figure 4). S. coelico-
lor shares its native soil environment with a host of
other microbial strains capable of secreting their own
antibiotic metabolites into their immediate surround-
ings, and it appears to have evolved to respond by acti-
vating production of its own bioactive metabolites.
Whether it does so as a form of retaliatory chemical
warfare or as a means of inter-species communication is
open to speculation.
Antibiotics as signalling molecules?
The production of metabolites with antibiotic activity is
a widespread trait of soil microorganisms, and must
confer some evolutionary advantage. While some of
these compounds may indeed be used to inhibit com-
peting species, they may also act as signalling molecules,
particularly at sub-inhibitory concentrations [74-77],
where they can modulate the transcriptional profiles of
other bacteria [78-80]. The significant transcriptional
response of S. coelicolor to treatment with moenomycin
at levels corresponding to <5% of the MIC may repre-
sent another such example.
Conclusions
This work has used the novel approach of identifying
common and unique transcriptional changes following
the treatment of bacteria with three antibiotics that
share the same key cellular target (cell wall biosynthesis)
but differ at the molecular level in their mode of action.
The characterised responses provide a wealth of infor-
mation pertinent to generalised and antibiotic-specific
cellular processes important for resistance and adapta-
tion to the compounds used. Regulatory networks
known to govern responses to environmental and nutri-
tional stresses were shown to be at the heart of the
common antibiotic response, and likely help cells sur-
vive until any specific resistance mechanisms are fully
functional. Attenuation of these networks by mutation
increased susceptibility to antibiotic treatment. Genes
with putative roles in the extracellular synthesis and
remodelling of peptidoglycan exhibited antibiotic-speci-
fic transcriptional changes, as did genes encoding two-
component sensor systems and sigma factors. Antibiotic
susceptibility studies using mutants constructed on the
basis of the transcriptome profiling confirmed a role for
several genes in antibiotic resistance, validating the use-
fulness of the approach. This included genes encoding
two novel ABC transport systems required for bacitracin
resistance, and a penicillin-binding protein and lysyl-
tRNA synthetase that contribute to both bacitracin and
vancomycin resistance. These represent new leads for
further improving our understanding of how bacteria
resist antimicrobial treatments at the molecular level,
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knowledge which may well be vital in enabling the
future development of more effective antibiotics.
Materials and methods
Bacterial strains and culture conditions
S. coelicolor M600, a prototrophic plasmid-free deriva-
tive of S. coelicolor A3(2), was used for the microarray
study. Spores of S. coelicolor M600 were germinated and
grown to mid-log phase (OD600 nm approx. 0.5) in
NMMP as described previously [19,43,44]. Biological tri-
plicate cultures were treated at this point by adding a
sub-lethal concentration (10 μg/ml) of vancomycin,
bacitracin or moenomycin A and samples taken 0, 30,
60, 90 minutes after addition of the antibiotic. A nega-
tive control which received no antibiotic treatment was
also performed. All of the antibiotics used for this study
except moenomycin A were purchased from Sigma-
Aldrich. Purified moenomycin A was a kind gift from
Professor Peter Walzel in the University of Leipzig. All
strains used are listed in Table 3.
Paper disc assays were used to study the induction of
pigmented antibiotics by vancomycin. Spore lawns of
M600 and M570 were spread on SMMS agar plates
[81], and paper discs impregnated with vancomycin (or
blank) were immediately applied to the surface. Cultures
were incubated for 3 days at 30°C.
RNA isolation and DNA microarray analysis
RNA was isolated from liquid cultures according to
Hesketh et al. (2007) [21]. Purified total RNA (10 μg)
was processed into labelled and fragmented cDNA for
hybridisation to Streptomyces diS_div712a Affymetrix
GeneChip arrays as previously described [21]. Following
scanning of the arrays, the data quality was verified
using a variety of tools including the ‘affyPLM’, ‘affy’
and ‘simpleaffy’ packages for the statistical computing
environment R [82], quality control methods available
within GeneSpring 11 (Agilent), and data from report
files generated in the Affymetrix Genechip Operating
Software. One replicate from the bacitracin experiment
failed quality control and was excluded from further
analysis, leaving duplicate data for this antibiotic treat-
ment. All microarray data are available from ArrayEx-
press (http://www.ebi.ac.uk/arrayexpress/) under
accession number E-MEXP-3032.
To identify differentially expressed genes, array data
were first imported into GeneSpring 11 with normalisa-
tion using the Robust Multichip Average (RMA) algo-
rithm of Irizarry et al. [83]. The data were then filtered
to remove genes deemed to be expressed at a level
below reliable quantification by determining those with
a raw signal value below a defined background cut-off
value of 100 in all samples. The results were further fil-
tered to remove genes deemed to be unresponsive to
the conditions under test in the experiment by identify-
ing those with normalised expression values between
0.667-1.5 (1.5-fold change limit) in all conditions. The
filtered data (2789 genes) were then subjected to two-
way ANOVA to identify genes significantly altered
under the experimental conditions, contrasting the
expression values in each antibiotic-treated sample with
the corresponding time point from the untreated con-
trol. This was performed using the parametric test
option with a false discovery rate of P < 0.01. P-values
were corrected using the Benjamini and Hochberg false
discovery rate multiple testing correction procedure, and
were computed asymptotically. Details of the statistical
calculations used in the software can be accessed
through the manufacturer’s manual.
Gene ontology (GO) analysis was performed on lists of
differentially expressed genes to identify over-repre-
sented biological functions or processes using the S. coe-
licolor GOA annotation from EMBL-EBI (ftp://ftp.ebi.ac.
uk/pub/databases/GO/goa/proteomes/84.S_coelicolor.
goa) as listed on 17/12/2009. GO analyses were realised
using the Ontologizer tool (http://compbio.charite.de/
index.php/ontologizer2.html), performing term-for-term
hypergeometric testing with the Benjamini and Hoch-
berg false discovery rate correction, or a Bayesian mod-
elling approach using the model-based gene set analysis
(MGSA) option [84]. Statistical comparison of lists of
differentially expressed genes to in-house curated lists of
functionally related genes was performed using the ‘find
similar entity lists’ tool of Genespring 11. The results
(summarised in Tables 1 and 2) determined whether the
number of genes from a particular functional class were
over-represented in the data, and therefore biologically
meaningful, or could have occurred by chance. Absence
of a functional class in Tables 1 and 2 therefore does
not mean that all genes in that class are absent in the
data, but rather that the number of genes present could
have arisen simply by chance at the 5% probability level
used. Quality threshold (QT) clustering was performed
in Genespring 7.3.
Construction of mutant strains for determining their
antibiotic susceptibility
Targeted gene deletions were constructed using the
PCR-directed mutagenesis procedure of Gust et al. [85]
or by using transposon mutated cosmids from the
library of Bishop et al. [86]. Briefly, for PCR-directed
replacement of genes with an antibiotic resistance cas-
sette (e.g. aac(3)IV for apramycin resistance, hyg for
hygromycin resistance), cosmid DNA in E. coli was tar-
geted with a disruption cassette created by PCR using
gene-specific primers and pIJ773 (for aac(3)IV) or
pIJ10007 (for hyg) as template. Candidate antibiotic
resistant clones were verified by PCR and restriction
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digestion, and conjugated into S. coelicolor M600. Dou-
ble crossover integrants were selected as apramycin/
hygromycin resistant, kanamycin sensitive clones, and
verified by PCR. For transposon mutants, mutated cos-
mids from the library were conjugated into S. coelicolor
M600 and double crossover integrants were selected as
apramycin resistant, kanamycin sensitive clones.
Assay for determining the minimum inhibitory
concentration (MIC) of the antibiotics
Minimum inhibitory concentration (MIC) values were
evaluated using a method similar to that of Andrews
(2001) [87]. McFarland turbidity standards of 0 (1.0 ml
distilled water), 0.5 (5.0 μl 1.175% BaCl2, 995 μl 1%
H2SO4), 1 (10.0 μl 1.175% BaCl2, 990 μl 1% H2SO4), and
2 (20 μl 1.175% BaCl2, 980 μl 1% H2SO4) were prepared.
S. coelicolor spores from 20% glycerol stocks were added
to 1.0 ml distilled water until the turbidity of the spore
suspension was between McFarland standards 1 and 2.
Spore suspensions were stored at 4°C and used within 1
week, during which time they showed no loss of viabi-
lity. 5.0 μl aliquots of the spore suspensions were
spotted onto a series of MMCGT agar plates [19] con-
taining the antibiotic under test at a range of concentra-
tions (vancomycin 30-150 μg/ml in 10 μg/ml
increments; bacitraicin 10-45 μg/ml in 5 μg/ml incre-
ments; moenomycin 0-300 μg/ml in 20 and 50 μg/ml
increments). The spots were allowed to dry, and the
plates were incubated at 30°C. MIC values were deter-
mined by visual inspection of growth over the range of
antibiotic concentrations after 48 hrs incubation.
Analysis of intracellular nucleotide pools
Quantification of intracellular nucleotides was per-
formed by HPLC as described in Hesketh et al. [21].
Duplicate cultures of S. coelicolor grown to mid-expo-
nential phase (OD600 nm approx. 0.5) and treated with
10 μg/ml vancomycin were extracted and analysed at 0,
15 30 and 60 min following addition of the antibiotic.
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Additional file 1: Summary of transcriptome analysis of genes
significantly differently expressed in response to vancomycin
treatment.
Additional file 2: Summary of transcriptome analysis of genes
significantly differently expressed in response to bacitracin
treatment.
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significantly differently expressed in response to moenomycin
treatment.
Additional file 4: Normalised expression data for the differentially
expressed gene groups illustrated in the venn diagram of Figure
1B.
Additional file 5: Term for term GO analysis of the genes
significantly differently expressed in response to vancomycin.
Additional file 6: Term for term GO analysis of the genes
significantly differently expressed in response to bacitracin.
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significantly differently expressed in response to moenomycin.
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Additional file 9: MGSA GO analysis of the genes significantly
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Additional file 10: MGSA GO analysis of the genes significantly
differently expressed in response to moenomycin.
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expressed gene groups illustrated in the venn diagram of Figure
1B.
Additional file 12: Analysis of the differentially expressed gene
groups illustrated in the venn diagram of Figure 1B, looking for
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Additional file 13: Genes whose expression following treatment
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